MONTESARCHIO, DANIELA
 Distribuzione geografica
Continente #
AS - Asia 9.627
NA - Nord America 8.930
EU - Europa 7.295
SA - Sud America 1.257
AF - Africa 260
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 27.400
Nazione #
US - Stati Uniti d'America 8.572
SG - Singapore 4.385
RU - Federazione Russa 3.004
VN - Vietnam 1.794
CN - Cina 1.760
IT - Italia 1.687
BR - Brasile 1.029
HK - Hong Kong 748
DE - Germania 527
FR - Francia 332
FI - Finlandia 297
UA - Ucraina 269
IE - Irlanda 267
CA - Canada 232
NL - Olanda 230
GB - Regno Unito 211
SE - Svezia 177
JP - Giappone 172
IN - India 145
AR - Argentina 104
BD - Bangladesh 98
MX - Messico 75
ZA - Sudafrica 74
TR - Turchia 70
CI - Costa d'Avorio 66
ES - Italia 65
PL - Polonia 59
KR - Corea 56
IQ - Iraq 50
TH - Thailandia 47
PH - Filippine 46
ID - Indonesia 40
PK - Pakistan 35
EC - Ecuador 31
MA - Marocco 30
BE - Belgio 25
TW - Taiwan 25
CO - Colombia 24
CZ - Repubblica Ceca 22
LT - Lituania 22
AU - Australia 21
UZ - Uzbekistan 19
VE - Venezuela 18
DZ - Algeria 16
PY - Paraguay 16
AT - Austria 15
IR - Iran 14
JO - Giordania 13
NP - Nepal 13
AE - Emirati Arabi Uniti 12
CL - Cile 11
EG - Egitto 11
MY - Malesia 11
SA - Arabia Saudita 11
KE - Kenya 9
TN - Tunisia 9
BG - Bulgaria 8
PT - Portogallo 8
CR - Costa Rica 7
DK - Danimarca 7
GR - Grecia 7
IL - Israele 7
KZ - Kazakistan 7
LB - Libano 7
PE - Perù 7
UY - Uruguay 7
BH - Bahrain 6
HU - Ungheria 6
RO - Romania 6
BW - Botswana 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NI - Nicaragua 5
NO - Norvegia 5
OM - Oman 5
AL - Albania 4
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
HN - Honduras 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
LY - Libia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
CG - Congo 3
CU - Cuba 3
EU - Europa 3
HR - Croazia 3
LC - Santa Lucia 3
MD - Moldavia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
ZM - Zambia 3
BS - Bahamas 2
Totale 27.327
Città #
Singapore 1.999
San Jose 1.182
Chandler 871
Moscow 753
Hong Kong 717
Ashburn 632
Beijing 527
Ho Chi Minh City 489
Hanoi 423
Napoli 345
Naples 315
Santa Clara 311
Jacksonville 258
The Dalles 256
Millbury 248
Los Angeles 237
Lauterbourg 233
Princeton 209
Amsterdam 198
Hefei 179
Nanjing 170
Houston 154
Boston 150
Tokyo 135
Munich 131
Ottawa 128
Woodbridge 128
Buffalo 113
New York 112
Dallas 100
São Paulo 95
Hamburg 90
Wilmington 89
Redondo Beach 78
Da Nang 70
Milan 69
Haiphong 66
Des Moines 65
Dong Ket 60
Rome 59
Ann Arbor 54
Council Bluffs 51
Seattle 50
Orem 49
Warsaw 48
Brooklyn 45
Helsinki 45
Turku 42
Denver 41
Lawrence 41
Chicago 40
Johannesburg 40
Jiaxing 39
Nanchang 39
Frankfurt am Main 38
Montreal 38
Hebei 37
Mexico City 37
Rio de Janeiro 37
Atlanta 36
London 36
Shenyang 35
Biên Hòa 32
Norwalk 30
Phoenix 30
Tianjin 30
Dublin 29
Falls Church 29
Changsha 28
Belo Horizonte 27
Seoul 27
Toronto 27
Düsseldorf 26
Boardman 25
Can Tho 25
Chennai 25
Manchester 25
Redwood City 25
San Francisco 24
Chengdu 23
Nuremberg 23
Stockholm 23
Augusta 21
Hải Dương 21
Cagliari 20
Dhaka 20
Falkenstein 20
Indiana 20
Madrid 20
Salerno 20
Brno 19
Curitiba 18
Kronberg 18
Pune 18
Bangkok 17
Guangzhou 17
Brasília 16
Sydney 16
Thái Bình 16
Casablanca 15
Totale 14.227
Nome #
CyPLOS, a new family of synthetic ion transporters 202
Functionalized hybrid magnetite gold nanoparticles with core-shell structure 197
Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides 195
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 178
Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes 175
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "INCROCI DI PAROLE". 175
Nanoparticelle ibride magnetite-oro con struttura nucleo-guscio funzionalizzate 175
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "BELLEZZA". 168
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 167
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 165
Fluorescence enhancement in G-quadruplex folding: synthesis, structure and stability of a novel dansyl-tagged, conjugated TBA 162
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "VEDERE". 161
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 160
Stability is not everything the case of the cyclization of the thrombin binding aptamer 157
Relazione struttura-stabilita' di quadruple eliche di DNA con attivita' anti-HIV 154
Breast cancer chemotherapeutic options: a general overview on the preclinical validation of a multi-target ruthenium(III) complex lodged in nucleolipid nanosystems 152
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "GENERE". 147
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 146
Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach 146
Solid phase synthesis of DNA-3'-PNA chimeras by using Bhoc/Fmoc PNA monomers 145
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 145
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 145
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 145
A new solid support for the synthesis of oligonucleotide-tetraphenylporphyrin conjugates 144
Ruthenium-based nanovectors for cancer therapy 144
Lipooligosaccharides as Amphiphiles to Build Liposomes for Effective Drug Delivery: The Case of Anticancer Ruthenium Complex-Based Aggregates 144
1-Substituted 2’-deoxyinosine analogues 143
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 141
A novel dansyl-labelled TBA15 analog showing fluorescence enhancement upon G-quadruplex formation for early detection of thrombin 140
On the binding of naphthalene diimides to a human telomeric G-quadruplex multimer model 140
Synthesis and NMR characterization of a novel crown ether ring-fused uridine analogue 138
Tailoring a lead-like compound targeting multiple G-quadruplex structures 138
Interference of polydatin/resveratrol in the ACE2:Spike recognition during COVID-19 infection. a focus on their potential mechanism of action through computational and biochemical assays 138
SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES TETHERED TO OLIGO-GLUCOSE PHOSPHATE TAILS 137
Huntingtin protein: A new option for fixing the Huntington's disease countdown clock 137
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 137
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 136
Innovation and Perspectives in Solid Phase Synthesis & Combinatorial Libraries 136
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "CASO". 136
Fluorescence enhancement in G-quadruplex folding: Synthesis, structure and stability of a novel dansyl-tagged, conjugated TBA 136
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 136
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 136
A New Competitive Fluorescence Assay for the detection of Patulin Toxin 135
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 135
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 134
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 133
Amphiphilic nucleoside complexes of ruthenium (III): a novel strategy in anticancer research 132
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 131
Dna binding mode analysis of a core-extended naphthalene diimide as a conformation-sensitive fluorescent probe of g-quadruplex structures 130
Design, Synthesis and Characterisation of novel amphiphilic guanosine derivatives 129
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 129
Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex 128
Exploring cellular uptake, accumulation and mechanism of action of an anticancer Ru(III) complex loaded into a nucleolipidic-based nanosystem in preclinical models of human breast cancer 128
6-Chloroxanthosine as useful intermediate for efficient syntheses of [6-15N]-isoguanosine, isoinosine and other purine nucleoside analogues 127
A new fluorescent TBA for early detection of thrombin: A biophysical study 127
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 126
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 126
Synthesis and biophysical characterization of G-rich oligonucleotides conjugated with sugar-phosphate tails 126
A new synthetic strategy for the prepartion of glyco-peptide conjugates 126
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 126
A new ferrocenemethyl-thymidine nucleoside: Synthesis, incorporation into oligonucleotides and optical spectroscopic studies on the resulting single strand, duplex and triplex structures 125
Solid phase approach to the preparation of small circular DNA and RNA fragments 124
CyPLOS, novel carbohydrate-based synthetic ion transporters 124
The role of G-quadruplex structures of LIGS-generated aptamers R1.2 and R1.3 in IgM specific recognition 124
B-Amino acid residues: Conformational characterization of an N- and C-protected homo-B-(S)-leucine 123
Guanosine-based amphiphiles: synthesis, biophysical characterization and biological activity 122
Developing functionalized Fe3O4-Au nanoparticles: A physico-chemical insight 122
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 122
Design, synthesis and characterization of a fluorescently labelled CyPLOS ionophore 121
Phosphocholine-decorated superparamagnetic iron oxide nanoparticles: defining the structure and probing in vivo applications 121
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 121
A new solid-phase synthesis of oligonucleotides 3’-conjugated with peptides 120
Nucleolipidic-based Ru(III) nanosystems induce multiple cell death pathways activation in preclinical models of human breast cancer 120
Nanostructuring of CyPLOS (Cyclic Phosphate-Linked OligoSaccharides), novel saccharide-based ion transporters 119
IV Convegno "Donne nella Scienza" 119
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 119
Method for the preparation of a low unspecific binding-support for affinity chromatography and/or on-line synthesis of oligonucleotides 119
Tesi di dottorato in Scienze Chimiche: SINTESI DI NUCLEOSIDI E NUCLEOTIDI MODIFICATI 118
2-(Phenylthio)-ethyl as a novel two-stage base protecting group for thymine analogues 118
CyPLOS: a new family of synthetic ionophores 118
5'-Modified G-quadruplex forming oligonucleotides endowed with anti-HIV activity: synthesis and biophysical properties 118
Design, Synthesis and Characterization of novel amphiphilic Guanosine-based Nucleolipids 118
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 118
CYCLIC URIDINE DIPHOSPHATE GLUCOSE, A NEW PYRIMIDINE ANALOG OF CYCLIC ADP RIBOSE 117
Fully automated synthesis of peptide-oligonucleotide conjugates 117
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase 117
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 117
Solid Phase Synthesis of cyclic PNA and PNA-DNA chimeras 116
Towards an analytical methodology for the screening of G-quadruplex-binding ligands 116
In vitro bioactivity of ruthenium-based multifunctional nucleolipidic liposomes: new promising agents for cancer therapy 116
On the interaction of an anticancer trisubstituted naphthalene diimide with G-quadruplexes of different topologies: a structural insight 116
Metodo per la preparazione di un supporto a basso legame aspecifico per cromatografia di affinità e/o sintesi diretta di oligonucleotidi 116
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 116
A facile solid-phase syntesis of oligonucleotides containing a 3’-3’ phosphodiester bond for alternate strand triple-helix formation 115
Solid phase synthesis of cyclic oligodeoxyribonucleotides intermolecular versus intramolecular coupling. 114
Anticancer cationic ruthenium nanovectors: from rational molecular design to cellular uptake and bioactivity 114
Synthesis and DNA Binding Properties of DNA-PNA Chimeras 113
Controlled Pore Glass-based oligonucleotide affinity support: towards High Throughput Screening methods for the identification of conformation-selective G-quadruplex ligands 113
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 113
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 112
Totale 13.458
Categoria #
all - tutte 87.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/20221.379 19 4 15 34 7 87 18 43 279 65 244 564
2022/20232.058 273 168 43 200 225 229 21 190 349 218 109 33
2023/20241.197 53 221 141 76 54 111 53 130 16 16 212 114
2024/20256.972 357 453 40 106 139 355 729 456 548 657 2.477 655
2025/202612.580 1.360 894 1.377 1.198 2.400 486 1.327 774 1.530 856 279 99
Totale 27.755